Share-based Payment Arrangement, Expense in USD of Inmune Bio, Inc. from Q4 2020 to Q3 2025
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
Inmune Bio, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and change rate from Q4 2020 to Q3 2025.
- Inmune Bio, Inc. Share-based Payment Arrangement, Expense for the quarter ending 30 Sep 2025 was $2.98M, a 73.6% increase year-over-year.
- Inmune Bio, Inc. annual Share-based Payment Arrangement, Expense for 2024 was $1.78M, a 75.9% decline from 2023.
- Inmune Bio, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $7.37M, a 3.06% increase from 2022.
- Inmune Bio, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $7.15M, a 49.1% increase from 2021.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)